These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 413764)

  • 1. [Modeling modification of chemical mutagenesis in human cells. 1. Elimination of chromosomal aberrations].
    Arutiunian RM; Oganian VK; Sarkisian TF
    Genetika; 1977; 13(9):1532-6. PubMed ID: 413764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modelling modification of chemical mutagenesis in human cells. III. Linear index of protection as the standardized criterion of modification].
    Kagramanian MS; Arutiunian RM; Egizarian SV
    Genetika; 1979; 15(1):84-8. PubMed ID: 118079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the cytogenetic activity of radioprotective agents in a human lymphocye culture. III].
    Arutiunian RM; Oganian VK
    Tsitol Genet; 1975; 9(5):369-9. PubMed ID: 809877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytogenetic activity of radioprotectors in a human lymphocyte culture. IV].
    Egiazarian SV; Arutinunian RM
    Tsitol Genet; 1977; 11(5):461-3. PubMed ID: 414395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modelling of a modification of chemical mutagenesis in human cells. II. The dependence of the effect on the time of culture treatment].
    Arutiunian RM; Sarkisian TF
    Genetika; 1978; 14(12):2205-8. PubMed ID: 217801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the radioprotective effectiveness of aminoalkylthiophosphoric derivatives. 2. The radioprotective effectiveness of sodium S-(S-thioethyl-2-amino)thiophosphate].
    Sverdlov AG; Grachev SA; Bondarev GN; Bogatyrev AV; Nikanorova NG
    Radiobiologiia; 1980; 20(1):75-9. PubMed ID: 7360920
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytogenetic activity of radioprotectors in a culture of human lymphocytes. V].
    Arutiunian RM; Danielian EA; Oganian VK; Sarkisian TF
    Tsitol Genet; 1978; 12(3):228-31. PubMed ID: 98875
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytogenetic activity of radioprotectors in a culture of human lymphocytes. VI].
    Danielian EA; Arutiunian RM; Ispirian SM
    Tsitol Genet; 1978; 12(5):437-40. PubMed ID: 103266
    [No Abstract]   [Full Text] [Related]  

  • 9. The apparent decrease in thiotepa-induced chromosome aberrations in human lymphocytes caused by an effect of WR2721 on the cell cycle as found by the definitively determined division method.
    Wolff S; Arutyunyan R
    Environ Mutagen; 1979; 1(1):5-13. PubMed ID: 233361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the cytogenetic activity of radioprotectors in a human lymphocyte culture. II].
    Arutiunian RM; Egiazarian SV
    Tsitol Genet; 1975; 9(4):295-8. PubMed ID: 813341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanism of selective action on warm-blooded animals and arthropods of S-ethinyl esters of thiophosphoric acid].
    Vikhreva LA; Nedel'kina SV; Solomennikova IV; Godovikov NN; Salganik RI
    Dokl Akad Nauk SSSR; 1988; 302(3):731-5. PubMed ID: 3229311
    [No Abstract]   [Full Text] [Related]  

  • 12. [Elimination of radiation-induced chromosomal damages in a human peripheral lymphocyte culture. I. The frequency of aberrations in the 1st and 2d mitoses].
    Piatkin EK; Nugis VIu
    Tsitologiia; 1981 Nov; 23(11):1310-6. PubMed ID: 7324170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Distribution and elimination of aminoproplaminoethylthiophosphoric acid in dogs].
    Il'in LA; Ivannikov AT; Konstantinova TP; Zherebchenko PG; Znamenskiĭ VV
    Med Radiol (Mosk); 1976 Mar; 21(3):71-3. PubMed ID: 1271995
    [No Abstract]   [Full Text] [Related]  

  • 14. [The cytogenetic effect of natural modifiers of mutagenesis in a human lymphocyte culture: the modification of the mutagenic effect by recombinant interferon in vitro in the lymphocytes of bronchial asthma patients and of healthy donors].
    Movsesian ES; Sarkisian TF; Arutiunian RM
    Tsitol Genet; 1990; 24(2):21-4. PubMed ID: 1695773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mathematical modeling of the relationship between the cytogenetic effect and the concentration of the mutagen].
    Chebotarev AN; Iakovenko KN
    Genetika; 1975; 10(8):150-7. PubMed ID: 817966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The distribution of chromosome aberrations after gamma and neutron irradiation among cells in various stages of the mitotic cycle in a human lymphocyte culture].
    Demina EA
    Radiobiologiia; 1989; 29(4):485-91. PubMed ID: 2780981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the interaction of acetylcholinesterase inhibitors with "catalytic" and "extra-catalytic" sites on the insolubilized enzyme.
    Friboulet A; Goudou D; Taylor P; Rieger F
    Prog Clin Biol Res; 1987; 253():277-86. PubMed ID: 3432291
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anticholinesterase properties and metabolism of new thiophosphonates with a carboxy ester bond in the phosphoryl portion of the molecule].
    Mikhaĭlov SS
    Vopr Med Khim; 1982; 28(4):79-83. PubMed ID: 7115520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statistical analysis of the elimination of chromosome-type aberrations and the fate of the aberrant cells].
    Iakovenko KN; Sapacheva VA
    Genetika; 1984 Jan; 20(1):144-54. PubMed ID: 6538155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Revision of th distribution of chromosome aberrations induced by chemical mutagens using the BUDR label].
    Chebotarev AN; Chernyshova NA
    Genetika; 1990 Aug; 26(8):1492-9. PubMed ID: 2258036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.